about
sameAs
What you don't know can kill you.Activity of Factor XII-Locarno.Clot stability as a determinant of effective factor VIII replacement in hemophilia A.Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.Correlates of plasma and platelet tissue factor pathway inhibitor, factor V, and Protein S.Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases.Safety and effectiveness of apixaban compared to warfarin in dialysis patientsGlobal public awareness about atrial fibrillationCost-minimization analysis of venous thromboembolism diagnosis: Comparison of standalone imaging with a strategy incorporating D-dimer for exclusion of venous thromboembolismStatin use and risk of recurrent venous thrombosis: results from the MEGA follow-up studyImaging platelet biogenesis in vivoCommon sequence variants associated with higher VWF and FVIII are less frequent in subjects diagnosed with type 1 VWDCurrent issues in diagnosis and treatment of von Willebrand diseaseNovel aspects of antiplatelet therapy in cardiovascular diseasePerforming and interpreting individual pharmacokinetic profiles in patients with Hemophilia A or B: Rationale and general considerationsAbstractDiversity and inclusion in a new medical journal: Advancing science in the 21st centuryA comprehensive targeted next-generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopeniaMeta-analysis: Key features, potentials and misunderstandingsAdrenaline enhances in vitro platelet activation and aggregation in blood samples from ticagrelor-treated patientsImpact of your results: Beyond the relative riskProtein S K196E mutation reduces its cofactor activity for APC but not for TFPIIn silico thrombin generation: Plasma composition imbalance and mortality in human immunodeficiency virusA multicenter study to evaluate automated platelet aggregometry on Sysmex CS-series coagulation analyzers-preliminary findingsPeak plasma concentration of direct oral anticoagulants in obese patients weighing over 120 kilograms: A retrospective studyAnalysis of procoagulant phosphatidylserine-exposing platelets by imaging flow cytometryMeasurement of coagulation factors during rivaroxaban and apixaban treatment: Results from two crossover trialsEvaluation of a semi-automated von Willebrand factor multimer assay, the Hydragel 5 von Willebrand multimer, by two European CentersSystematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trialsPreoperative screening for bleeding disorders: A comprehensive laboratory assessment of clinical practiceCancer-associated thrombosis: The search for the holy grail continuesSalivary tissue factor induces thrombin generation in a diurnal rhythmGenomics and transcriptomics of megakaryocytes and platelets: Implications for health and diseaseComparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clotsIndoleamine 2,3-dioxygenase 1 in coronary atherosclerotic plaque enhances tissue factor expression in activated macrophagesIdentification and characterization of novel mutations implicated in congenital fibrinogen disordersManagement of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic reviewSerial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE StudyDifferences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndromeISSUE INFORMATION
P1433
Q52699849-82A8DBEC-8F26-41E7-9DB4-182E5B556551Q52735481-8F0D30E3-0EF2-4382-9D99-578F1ED0F05BQ53068802-4097FCDA-36FB-41D2-857B-83A81F76ECF3Q55359034-7973CA3A-C022-4B09-BB66-D3CBE919F870Q55447752-6DA45498-6D47-48D0-8EFE-FA2944622D6FQ55652795-9332A332-9CE3-4A58-894B-0391B63165B5Q56380572-A10A1A10-BBC9-441E-8439-5FA75124B172Q56913123-6209459F-CD78-4684-9DE3-62DDC0C3AE60Q56959579-170E1106-F5C3-4AEE-9435-FE6C52A6C25CQ56968545-1AD03F81-BC17-4BB3-AE83-8F67F37277D4Q56990409-2D022378-5E39-4946-9D97-8289E91A063AQ57094753-3E2A0F3E-C2AD-412F-9D34-11A2D85B0D8DQ57095004-92A243EA-BD91-48BB-BA62-AABD552A79E9Q57179203-C941F7FF-8648-46C5-BE4A-AE4CAE31D6A1Q57179210-54B70F6B-3D0B-4858-BBD6-FED1C8C4363BQ57652819-79EC32C3-EE94-4525-9DAE-A944D8B9FBA5Q57816351-BD6EE0B8-D8AF-43AA-A8DA-9CB47378C980Q57817723-5EBE322F-8D1D-4F7D-B4C5-64FA7CB6C997Q57818215-96D5CFDA-C3CD-4144-A4E3-F3F6B7449CD2Q57820859-A60C860E-2B10-47A9-B7FC-E72DFA4ADA67Q57820861-7345BE3B-39B6-44BC-861F-1DAE0E361BEEQ57821577-86C655A4-9523-4629-AA52-C678504A1849Q57822378-F67C169A-6646-48A1-AA12-8A9152E6DB34Q57823474-0872406B-508D-462D-B683-561FA7711B70Q57823505-B6DC3814-F137-4349-9209-D602B39C10B9Q57823620-F7A29C3A-20A5-4B4C-BADF-C222D1CC2992Q57823773-CE72DA9B-D071-42F5-B440-2834EA7388C1Q57824128-B363C73D-9D6D-4B2A-AFAA-19D437387C36Q57824209-86B98DC8-B15F-465E-8367-DB6863B008E0Q57824750-8E4C545D-2047-4BBD-A732-ADFE8D614F26Q57824763-DB5EA349-B7C8-40A6-ADA5-236375ABF94BQ57824795-67344D32-762A-4172-B59C-EBFE0900DCC5Q57824804-D4A01F69-A1C9-413C-91ED-92AA1EBF8399Q57824809-1337D096-58ED-4BBD-9FDD-01326E8DED9BQ57824840-28979467-92E2-4F08-90FA-F347F8389E30Q57824871-59F64D0F-0514-4521-A456-6F04DE00F29DQ57825250-79A8C098-2ED7-4BA9-80BD-274A43F6A90BQ57825251-C03C27EC-D582-4704-9EE4-AA1BE83823B1Q58580854-667E14EF-74D2-4925-9D2D-70257BB6CB08Q58776137-11F966E0-F4DF-4EF7-926D-A20EA6D5D55E
P1433
description
Academic journal published by ...... blood and blood-forming organs
@en
academisch tijdschrift
@nl
name
Research and Practice in Thrombosis and Haemostasis
@en
Research and Practice in Thrombosis and Haemostasis
@nl
type
label
Research and Practice in Thrombosis and Haemostasis
@en
Research and Practice in Thrombosis and Haemostasis
@nl
prefLabel
Research and Practice in Thrombosis and Haemostasis
@en
Research and Practice in Thrombosis and Haemostasis
@nl